Drug Safety

Vision Disorders and Phosphodiesterase Type 5 Inhibitors: A Review of the Evidence to Date
pp. 1-18(18)
Author: Laties, Alan M.

Determinants of Under-Reporting of Adverse Drug Reactions: A Systematic Review
pp. 19-31(13)
Authors: Lopez-Gonzalez, Elena; Herdeiro, Maria T.; Figueiras, Adolfo

Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis: A Multicentre, Open-Label Study in Spain
pp. 33-42(10)
Authors: Valero, Antonio; >Fernando de la Torre,; Castillo, José Antonio; Rivas, Pilar; >Alfonso del Cuvillo,; Antépara, Ignacio; Borja, Javier; Donado, Esther; Molà, Oriol; Izquierdo, Iñaki

Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England: Results from a Modified Prescription-Event Monitoring Study
pp. 43-54(12)
Authors: Aurich-Barrera, Beate; Wilton, Lynda V.; Shakir, Saad A.W.

Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
pp. 55-68(14)
Authors: Fontana, Robert J.; Watkins, Paul B.; Bonkovsky, Herbert L.; Chalasani, Naga; Davern, Timothy; Serrano, Jose; Rochon, James

Platelet Measurements versus Discharge Diagnoses for Identification of Patients with Potential Drug-Induced Thrombocytopenia: A Cross-Sectional Study in the Netherlands
pp. 69-76(8)
Authors: Berg, Maarten J. ten; van Solinge, Wouter W.; >Patricia M.L.A. van den Bemt,; Huisman, Albert; Schobben, Alfred F.A.M.; Egberts, Toine C.G.

An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians: A Time Series Analysis in Spain
pp. 77-83(7)
Authors: Pedrós, Consuelo; Vallano, Antoni; Cereza, Gloria; Mendoza-Aran, Gemma; Agustí, Antònia; Aguilera, Cristina; Danés, Immaculada; Vidal, Xavier; Arnau, Josep M.

Drug-Induced Thrombocytopenia: An Updated Systematic Review, 2008
pp. 85-86(2)
Authors: Swisher, Karen K.; Li, Xiaoning; Vesely, Sara K.; George, James N.